These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17473452)

  • 21. Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists.
    Fujisawa T; Adachi K; Komazawa Y; Mihara T; Azumi T; Katsube T; Furuta K; Kazumori H; Kinoshita Y
    Aliment Pharmacol Ther; 2004 Sep; 20(5):559-65. PubMed ID: 15339327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons.
    Sano T; Utsumi D; Amagase K; Matsumoto K; Tominaga M; Higuchi K; Takeuchi T; Kato S
    J Physiol Pharmacol; 2017 Feb; 68(1):79-90. PubMed ID: 28456772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
    Yoneda M; Kurosawa M; Watanobe H; Terano A
    J Gastroenterol Hepatol; 2003 Feb; 18(2):177-84. PubMed ID: 12542603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple, sensitive and rapid LC-ESI-MS method for the quantitation of lafutidine in human plasma--application to pharmacokinetic studies.
    Chen WD; Liang Y; Li H; Xiong Y; Liu XD; Wang GJ; Xie L
    J Pharm Biomed Anal; 2006 Apr; 41(1):256-60. PubMed ID: 16298507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M; Banba M; Joko A; Moriyama Y
    Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lafutidine, a histamine H2-receptor antagonist, on gastric mucosal blood flow and duodenal HCO3- secretion in rats: relation to capsaicin-sensitive afferent neurons.
    Mimaki H; Kagawa S; Aoi M; Kato S; Satoshi T; Kohama K; Takeuchi K
    Dig Dis Sci; 2002 Dec; 47(12):2696-703. PubMed ID: 12498288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of famotidine in children.
    James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats].
    Onodera S; Tanaka M; Aoyama M; Arai Y; Shibata M; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):167-75. PubMed ID: 9583080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early effects of oral administration of lafutidine with peppermint oil, compared with lafutidine alone, on intragastric pH values.
    Iida H; Inamori M; Uchiyama T; Endo H; Hosono K; Akiyama T; Sakamoto Y; Fujita K; Takahashi H; Yoneda M; Koide T; Tokoro C; Goto A; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
    Hepatogastroenterology; 2011; 58(105):235-8. PubMed ID: 21510321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiulcer effect of lafutidine on indomethacin-induced gastric antral ulcers in refed rats.
    Onodera S; Tanaka M; Aoyama M; Arai Y; Inaba N; Suzuki T; Nishizawa A; Shibata M; Sekine Y
    Jpn J Pharmacol; 1999 Jul; 80(3):229-35. PubMed ID: 10461768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.
    Ichikawa T; Ota H; Sugiyama A; Maruta F; Ikezawa T; Hotta K; Ishihara K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1800-5. PubMed ID: 17914953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Oshitani N; Fujiwara Y; Arakawa T
    Inflammopharmacology; 2006 Dec; 14(5-6):226-30. PubMed ID: 17186182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
    Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
    Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU
    Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus in rats].
    Kagoshima M; Kodaira H; Shimada H
    Nihon Yakurigaku Zasshi; 1994 Nov; 104(5):379-89. PubMed ID: 7829023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
    Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
    Gardner JD; Ciociola AA; Robinson M; McIsaac RL
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.